Last update 17 May 2025

Ceftriaxone Sodium/Tazobactam Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
PBPs x β-lactamase
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesUrogenital Diseases
Active Indication
Bacterial InfectionsBacterial lower respiratory infectionGenitourinary tract infection+ [7]
Inactive Indication-
Originator Organization
Haikou Qili Pharmaceutical Co., Ltd.Haikou Qili Pharmaceutical Co., Ltd.
Active Organization
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.Haikou Qili Pharmaceutical Co., Ltd.Haikou Qili Pharmaceutical Co., Ltd.
Inactive Organization
China Pharma Holdings, Inc.China Pharma Holdings, Inc.
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (09 Apr 2009),
Bacterial Infections
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H20N8NaO8S3
InChIKeyKFQRYHQOZUTRQJ-BBJOQENWSA-N
CAS Registry104376-79-6
View All Structures (2)

Related

4
Clinical Trials associated with Ceftriaxone Sodium/Tazobactam Sodium
CTR20132852
/ Active, not recruitingPhase 2
注射用头孢曲松钠他唑巴坦钠（6:1）治疗中、重度下呼吸道和泌尿系统急性细菌感染Ⅱ期临床试验
[Translation] Phase II clinical trial of ceftriaxone sodium and tazobactam sodium for injection (6:1) in the treatment of moderate to severe acute bacterial infections of the lower respiratory tract and urinary system
CTR20132376
/ CompletedPhase 1
单中心、开放、随机分组注射用头孢曲松钠他唑巴坦钠单、多次给药药代动力学及相互作用临床研究
[Translation] A single-center, open-label, randomized clinical study on the pharmacokinetics and interactions of single and multiple doses of ceftriaxone sodium and tazobactam sodium for injection
CTR20130987
/ RecruitingPhase 2
注射用头孢曲松钠他唑巴坦钠（6:1）治疗中、重度下呼吸道和泌尿系统急性细菌感染的Ⅱ期临床试验
[Translation] Phase II clinical trial of ceftriaxone sodium and tazobactam sodium for injection (6:1) in the treatment of moderate to severe acute bacterial infections of the lower respiratory tract and urinary system
100 Clinical Results associated with Ceftriaxone Sodium/Tazobactam Sodium
Login to view more data
100 Translational Medicine associated with Ceftriaxone Sodium/Tazobactam Sodium
Login to view more data
100 Patents (Medical) associated with Ceftriaxone Sodium/Tazobactam Sodium
Login to view more data
100 Deals associated with Ceftriaxone Sodium/Tazobactam Sodium
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bacterial Infections
China
Haikou Qili Pharmaceutical Co., Ltd.Haikou Qili Pharmaceutical Co., Ltd.
09 Apr 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bacterial lower respiratory infectionPhase 3
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
16 Apr 2015
Genitourinary tract infectionPhase 3
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
16 Apr 2015
Acute BronchitisPhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
Acute pyelonephritisPhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
BronchiectasisPhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
Community Acquired PneumoniaPhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
Complicated urinary tract infectionPhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
Hospital-acquired pneumoniaPhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
Pulmonary Disease, Chronic ObstructivePhase 2
China
Xiangbei Welman Pharmaceutical Co., Ltd.Xiangbei Welman Pharmaceutical Co., Ltd.
17 May 2011
Lower Respiratory Tract InfectionsPhase 1
China
China Pharma Holdings, Inc.China Pharma Holdings, Inc.
22 Jul 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free